Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIGID
2023-506949-27-00Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in secondary osteoporosis comparing Prednisolone with Placebo (2 arms). Started Mar 2024; status: completed.
02
Drugs
prednisolone
03
Conditions
secondary osteoporosis
Beyond the preview
Go deeper on 2023-506949-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506949-27-00.